Our Leadership

Chief Executive Officer & Board Member

Member of MGX Board of Directors, member of MGX Board Executive Committee and Chairman of MGX Investment Committee

Ahmed Yahia Al Idrissi is the CEO of MGX. He was previously CEO of Direct Investments at Mubadala, where he oversaw investments in the energy, technology, life sciences, consumer, industrial, and financial services sectors.

Prior to his roles at Mubadala and MGX, Yahia was a Partner at McKinsey & Company, where he co-led the Principal Investor practice and was also the Managing Partner of the Abu Dhabi practice. He was formerly a Marketing Manager at Procter & Gamble, where he led several flagship brands.

Yahia serves as the Chairman of the Board of Directors of GlobalFoundries and CEPSA and is a member of the board of directors of Abu Dhabi Investment Council, Mubadala Capital and Emirates Global Aluminium. He is a member of Mubadala Investment Committee. Previously, he served as a board member of AMD from 2012 to 2019.

He holds a Bachelor of Science in Industrial Engineering from École Centrale Paris and a Master of Science in Mechanical Engineering/Product Strategy from the Massachusetts Institute of Technology. Yahia is an independent non-executive director under applicable Nasdaq rules.

Chief Operating Officer and Chief Finance Officer

Member of MGX Investment Committee and Co-Chair of MGX Management Committee

Danny Dweik is MGX’s Chief Operating Officer and Chief Finance Officer. He was previously an Executive Director at Mubadala, where he led the Industrials and Business Services sector as well as the Energy and Sustainability sector as part of the Direct Investments platform.

During his tenure at Mubadala, Danny held key leadership roles, including serving as Chief Executive Officer of Nova Chemicals, one of Mubadala’s largest assets. He also served as Chief Executive Officer and Chief Financial Officer of Emirates Global Aluminium (EGA), where he led the post-merger integration and revenue growth program.

Prior to joining Mubadala, Danny was an Associate Partner at McKinsey & Company, where he led engagements for clients in multiple industries and across various strategic topics, including strategy development, operational and performance transformation, M&A and financial due diligence.

He holds an MPA from Harvard University, an MBA from McGill University and a BS degree in Accounting & Finance from the Lebanese American University.

Chief Investment Officer, Technology

Member of MGX Investment Committee

Ali Osman is Chief Investment Officer at MGX, overseeing AI, AI-enabled technology, and global infrastructure investments.

Before joining MGX, Ali spent over 15 years at Mubadala Investment Company, where he led multiple investment teams and units, managing a portfolio exceeding $10 billion in assets under management. He established Mubadala’s Technology unit within the Direct Investments platform, overseeing over $4 billion in investments across software and techenabled services while leading a team of more than 25 investment professionals across offices in Abu Dhabi and New York. Additionally, Ali co-founded Mubadala’s Life Sciences unit, contributing to over $5 billion in strategic investments in the sector.

Ali has served on the boards of organizations including Avalara, Outset Medical, Sterling Pharmaceutical Solutions, and Envision Pharma Group.

He holds an MBA from Harvard Business School and a Bachelor of Science in Mechanical Engineering from Tufts University.

Chief Investment Officer Industrial & Life Science

Member of MGX Investment Committee

Guy Harmelin is Chief Investment Officer of the MGX Industrial & Life Science portfolio responsible for MGX AI-enabled industrial and life science investments.

Prior to MGX, Guy was senior advisor to the CEO of Group 42 and to CIM Group, a US based real asset manager with over $30 billion in AUM.

Guy was previously an investment executive at 7-main, a single-family office focusing on industrial and deep technology investments. Before 7-main, Guy led the direct technology investment arm at Harel Insurance Investments and Financial Services, the largest insurance group in Israel with over $120 billion in assets under management.

Prior to joining Harel, Guy was the co-founder and CEO of RondinX, a computational drug target discovery company which merged with BiomX and went public on NYSE in November 2019, and co-founder of Ayala Pharma which went public on NASDAQ in 2021 and was acquired by Immunome.

Guy has an MD from the University of Florence and served as a Resident Physician at the Tel Aviv Medical Center.

Member of MGX Investment Committee and member of MGX Management Committee

Omar Alismail is Chief Buildout Officer of the MGX Semiconductors, Regional Infrastructure and Operating Partners groups.

Prior to MGX, Omar established the Mubadala Operating Partners team with 20+ senior executives focused on critical value creation capabilities for Mubadala portfolio companies (e.g., Digitization, Go-to-Market, Operations). During his time at Mubadala, he oversaw value creation across the Mubadala portfolio, generating an estimated ~$2.5bn in incremental EBITDA through transformation initiatives. Prior to establishing the Mubadala Operating Partners group, Omar served as Deputy CFO of GlobalFoundries and co-led the company’s landmark IPO in 2021.

Omar’s previous and current Board observer positions include GlobalFoundries, TM Mining Ventures and Sociedad Minera de Santander.

Omar is a CFA Charterholder, holds an MSc Finance from Imperial College of London, and BSc in Business Administration from American University of Sharjah.

Chief People Officer

Member of MGX Management Committee

Laila Saif is the Chief People Officer at MGX, where she oversees the overall talent agenda across multiple spectrums including acquisition, organizational culture, employee experience & growth. With over 21 years of international HR leadership experience, including 12 years at Mubadala group companies, Laila has a proven track record of delivery across multiple sectors.

Before joining MGX, Laila served as Director of Human Capital at Emirates Global Aluminium, where she led a team of 60+ HR professionals and implemented HR strategies for over 7,000 employees.

Previously, she founded a successful corporate wellness company and, prior to this, was Head of Human Capital Business Partners at Mubadala, driving initiatives to enhance operational efficiency through a robust operating model and was involved in several strategic initiatives across the platform. Earlier in her career, Laila worked with GE Capital in Germany and the UK, spearheading talent development initiatives. She also played a key role in advising the leadership of EDGE Group on the comprehensive restructuring and transformation program that consolidated 16 advanced technology and defense companies into a unified platform.

Laila holds an EMBA from the Higher Colleges of Technology, Abu Dhabi, and is a recipient of the Abu Dhabi Industry Award for outstanding academic achievement.

Chief Legal Officer

Member of MGX Investment Committee and member of MGX Management Committee

Andre is responsible for the company’s legal and compliance functions, including all investment related activity, governance and regulatory compliance. He also serves as a member of MGX’s Investment Committee, which reviews and approves proposed transactions and projects, and as a member of MGX’s Management Committee, which reviews and approves policies and procedures.

Prior to MGX, Andre was the General Counsel of Direct Investments at Mubadala Investment Company, where he provided legal oversight for Mubadala’s technology, healthcare, consumer, energy & sustainability, financial services and industrials & business services investments. Andre also served as a member of the Direct Investments Platform Investment Committee, which reviews and approves proposed projects and transactions within the platform. He also served in a variety of other roles at Mubadala commencing in 2010, including as General Counsel of Corporate Finance & Treasury. Before joining Mubadala, Andre worked at Sullivan & Cromwell LLP in New York and Hong Kong.

Andre received his Bachelor of Arts degree from Harvard University, his D.Phil. from Oxford University, where he was a Rhodes Scholar, and his law degree from the Yale Law School.